CURRICULUM VITAE
Name:
Roberto M. Lemoli
Date of Birth:
05/29/1959
Nationality:
Italian
Status:
Married
EDUCATION
March 1985 - Degree of Doctor of Medicine at the University of Bologna with the
score of 110/110 cum laude.
July 1988 - Fellowship in Oncology-Hematology at the University of Bologna with
the score of 70/70 cum laude.
TRAINING - FELLOWSHIP
1985-1988 - Fellow of the Hematology-Oncology Dept. at the University Hospital in
Bologna.
1988-1991 - Research Fellow at the Dept. of Medicine Memorial Sloan-Kettering
Cancer Center, New York, NY.
1989 March - Visiting Doctor at Fred Hutchinson Cancer Center (FHCRC), Seattle
WA.
1996 July - Visiting Doctor at MD Anderson Cancer Center (MDACC), Houston
TX.
1996 August - Visiting Doctor at FHCRC, Seattle, WA.
2004 May – Visiting Doctor at the Center for Cell and Gene Therapy, Baylor College
of Medicine, Houston, TX, USA.
AFFILIATIONS
From 1992 - Attending Physician at the Institute of Hematology “Seràgnoli”,
University of Bologna.
From 1992 - Head of the laboratory of "Hematopoietic stem cell biology and
transplantation", Head of the “Stem cells and Regenerative Medicine, Immunology
and Immunotherapy, Cell therapy”, Institute “Seràgnoli”, University of Bologna.
From 2005 Associate Professor of Hematology, University of Bologna.
MEMBERSHIP SCIENTIFIC SOCIETIES
1985 - Member Italian Society of Hematology.
1987 - Member Italian Society of Experimental Hematology.
1988-1989 - Fellow of the Italian Association for the Research against Cancer.
1992 - Member American Society of Hematology.
1993- Member of the International Society of Experimental Hematology.
2002-2006 Member of the Board of the Italian Society of Experimental Hematology
2004–2006 Vice-President of the Italian Society of Experimental Hematology
2012- President of the Italian Society of Experimental Hematology
Reviewer: Haematologica, Leukemia and Lymphoma, Journal of Hematotherapy,
Cytotherapy, Bone Marrow Transplantation, Experimental Hematology, Blood,
Journal of Immunology.
Editorial board:
Haematologica (1997-); Experimental Hematology (2003-2005)
TOTAL IMPACT FACTOR (2011): 995,09 (Mean Impact factor = 5,82)
FIRST/LAST AUTHOR IMPACT FACTOR :
601,83 (Mean Impact = 5,95)
Journal
impact factor
No. papers (first/last)
(second/others)
Blood
9.89
21
(9/10)
(1/1)
J Clin Oncol
18.37
3
(1)
(0/2)
Exp Hematol
2.90
15
(7/6)
(1/1)
Transplantation
4
3
(1)
(1/1)
Br J Haematol
4.94
16
(4/4)
(1/7)
Leukemia
9.56
4
(1/1)
(1/1)
Bone Marrow Transpl 3.74
18
(4/1)
(3/10)
Haematologica
6.42
37
(20/6)
(1/10)
Cancer Journal
3.25
1
(1/0)
Stem Cells
7.78
(ex Int J Cell Cloning)
6
(2/2)
(2/0)
Acta Haematol
1.35
2
(1/0)
(1/0)
Leukemia Lymphoma 2.58
9
(3/1)
(2/3)
Lancet
38.27
1
J Immunol
5.78
5
(0/3)
(0/2)
Annals Hematol
(ex Blut)
Cancer Res
2.61
3
(0/1)
(1/1)
7.85
1
(0/1)
(0/1)
Bailliere’s Clin Hematol 2.63
1
Eur J Hematol
2.61
3
(1/2)
Cancer Immunol
3.07
2
(0/2)
Eur J Cancer
5.53
1
Cryobiology
2.06
1
(1/0)
(0/1)
(0/1)
J Immunol Methods 2.20
2
(0/2)
Cancer Chem Pharm 2.83
1
(0/1)
Cytotherapy
(ex J Hematother)
3.62
1
(1/0)
J Biol Reg
5.18
Homeostatic Agents
2
(0/2)
Eur J Immunol
5.10
1
Immunol Letters
2.52
1
(0/1)
BBMT
3.87
2
(0/1)
Dig Liver Dis
3.05
1
(0/1)
Aliment Pharm Ther 3.76
1
(0/1)
Journal Hepatol
9.26
Transfusion
3.21
British J Cancer
5.04
Curr Opin Oncol
4.01
1
Stem Cells and Dev. 4.45
1
(0/1)
1
(0/1)
(0/1)
2
(0/1)
1
(0/1)
(0/1)
(1/0)
(0/1)
UP TO 31/01/2013
TOTAL NUMBER OF PEER-REVIEWED PAPERS = 171
FIRST/LAST AUTHOR= 101
TOTAL IMPACT FACTOR = 995,09 (Mean Impact factor = 5,82)
FIRST/LAST AUTHOR IMPACT FACTOR = 601,83 (Impact factor medio = 5,95)
H INDEX= 38 (according to Google Scholar) , N.78 ranking according to:
www.topitalianscientists.org